Toxicological testing is essential for determining the safety of chemicals and pharmaceuticals. The cost of these tests can be significant, as they often involve complex in vivo and in vitro studies. Advanced methods like high-throughput screening and omics technologies have been developed to reduce costs and increase efficiency. However, the initial investment in equipment and training can be substantial. The financial burden of testing can affect smaller companies disproportionately, potentially limiting innovation in chemical safety.
